Stephane Cheze

Caen, 14000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications

Efficacy and safety of high doses of eltrombopag for treating adult immune thrombocytopenia: Results from a multicentre retrospective cohort study.

Efficacy and safety of high doses of eltrombopag for treating adult immune thrombocytopenia: Results from a multicentre retrospective cohort study.

Journal: British journal of haematology
Published: April 02, 2026

Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.

Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.

Journal: American journal of hematology
Published: September 18, 2025

Short- and long-term outcome of neonates with thrombocytopenia from maternal immune thrombocytopenia.

Short- and long-term outcome of neonates with thrombocytopenia from maternal immune thrombocytopenia.

Journal: British journal of haematology
Published: July 04, 2025

Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN-France.

Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN-France.

Journal: American journal of hematology
Published: March 28, 2025

Efficacy and safety of dapsone in adult primary immune thrombocytopenia.

Efficacy and safety of dapsone in adult primary immune thrombocytopenia.

Journal: Blood advances
Published: September 26, 2024

Long-term follow-up of the STOPAGO study.

Long-term follow-up of the STOPAGO study.

Journal: Blood
Published: June 24, 2024

Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.

Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.

Journal: British journal of haematology
Published: July 15, 2023

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.

Journal: Blood
Published: March 01, 2023

Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial.

Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial.

Journal: Leukemia research
Published: December 30, 2022

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.

Journal: Blood
Published: October 27, 2022

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.

Journal: Blood
Published: June 09, 2022

Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia.

Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia.

Journal: British journal of haematology
Published: April 19, 2022
Showing 1-12 of 54

Last Updated: 09/26/2026